У нас вы можете посмотреть бесплатно Predictable regeneration using OSSIX™ Bone, a sugar cross-linked ossifying collagen scaffold или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Predictable regeneration using OSSIX™ Bone, a sugar cross-linked ossifying collagen scaffold Presented during the Dentsply Sirona Corporate Forum at the 2021 AO meeting by Matt Fien, DDS Dr. Fien will discuss the benefits and versatility of OSSIX™ Bone for a wide variety of regenerative procedures. In addition, several cases will be presented that illustrate its superior handling and regenerative potential. Speaker Disclosure: Speaker received compensation from Dentsply Sirona for the production of this content. All opinions expressed by the Speaker are those of the Speaker and do not necessarily reflect the views of Dentsply Sirona. Dentsply Sirona does not guarantee any results or outcomes. Dentsply Sirona does not endorse any third-party products, service providers, or services referenced by the Speaker This webinar is provided as an inspiration for you as a clinician and not necessarily as a recommendation from Dentsply Sirona. Dentsply Sirona Implants is committed to new and innovative knowledge, however sponsorship by Dentsply Sirona Implants does not necessarily imply endorsement of a particular philosophy, procedure or product. All trademarks, company names and implant designs are the property of their respective owners. All information provided is for educational and informational purposes only. The content shared in this presentation is not medical advice and should not be relied on as such. This presentation may not cover all possible drug interactions, FDA warnings, or alerts. Contact a physician if you have health questions or concerns relating to interactions or visit FDA.gov for further information.